Search - tctmd.com

Displaying 261 - 280 of 39119

Sort: Relevancy | Date

Presentation THT 2026

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Presenter: Kathy Ivey

March 02, 2026

Presentation THT 2026

Intraaortic Balloon Pump in Cardiogenic Shock: Did We Rush to Bury It?

Presenter: Maya Guglin

March 02, 2026

Presentation THT Abstracts 2026

CARDIAC RECOVERY AFTER ABLATION FOR ATRIAL FIBRILLATION

Presenter: Jaclyn Hayma

March 02, 2026

Presentation THT 2026

Risk Redefined: Predictive Modeling and the AI-enabled HF Clinic

Presenter: Tariq Ahmad

March 02, 2026

Presentation THT 2026

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Presenter: James F. Martin

March 02, 2026

Presentation THT 2026

Characterizing Hemodynamic Phenotypes In Patients Not Meeting Diagnostic Criteria for Primary Graft Dysfunction

Presenter: Caroline Magro

March 02, 2026

Presentation THT 2026

Adjunctive Supersaturated Oxygen Therapy Following PCI in Acute Coronary Syndrome With Cardiogenic Shock: A Randomized Study

Presenter: Sanchit Kundal

March 02, 2026

Presentation THT 2026

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Presenter: Eric D. Adler

March 02, 2026

Presentation THT 2026

Characterizing the Untapped Pool of HIV+ Donors for Heart Transplantation

Presenter: Neha Parvathala

March 02, 2026

Presentation THT 2026

SHOCK-PRECISION: Early Phenotype-Guided Mechanical Circulatory Support in Cardiogenic Shock

Presenter: Juliana Giorgi

March 02, 2026

Presentation THT 2026

Beyond the Stethoscope: AI in HF Diagnosis and Phenotyping

Presenter: Heidi S. Hartman

March 02, 2026

Presentation THT Abstracts 2026

A Retrospective Analysis of Heart Failure Hospitalization Trends in Patients with Functional Mitral Regurgitation in a Real-world Clinical Setting

Presenter: Colin Barker

March 02, 2026

Presentation THT 2026

Artificial Intelligence: Framing the Future of HF Diagnostics and Clinical Decision Making

Presenter: Anuradha (Anu) Lala-Trindade (Lala)

March 02, 2026

Presentation THT 2026

PARACHUTE-PCI: An adaptive, sham-controlled, simultaneous crossover trial of microaxial flow pumps to prevent cardiogenic shock during high risk PCI

Presenter: Pankaj Jain

March 02, 2026

Presentation THT 2026

Overview of Gene Therapies for Specific Cardiomyopathies

Presenter: Barry Greenberg

March 02, 2026

Presentation THT 2026

Not Quite PGD: Classification of Abnormal Hemodynamic Phenotypes after Heart Transplant

Presenter: Jordan Liebman

March 02, 2026

Presentation THT 2026

The Emperor Rises: First In Vitro and In Vivo Evaluation of SynCardia’s Electromechanical Total Artificial Heart

Presenter: Andre Simon

March 02, 2026

Presentation THT 2026

No: Only Select Patients Should Receive a Remote Monitoring Device

Presenter: JoAnn Lindenfeld

March 02, 2026

Presentation THT 2026

Yes: Most Patients Discharged from a HF Hospitalization Should Receive a Remote Monitoring Device

Presenter: Nir Uriel

March 02, 2026

Presentation THT 2026

NO: The Evidence is Not Strong Enough to Support TEER in Moderate MR in HF

Presenter: Gregg W. Stone

March 02, 2026

Advertisement

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Intraaortic Balloon Pump in Cardiogenic Shock: Did We Rush to Bury It?

CARDIAC RECOVERY AFTER ABLATION FOR ATRIAL FIBRILLATION

Risk Redefined: Predictive Modeling and the AI-enabled HF Clinic

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Characterizing Hemodynamic Phenotypes In Patients Not Meeting Diagnostic Criteria for Primary Graft Dysfunction

Adjunctive Supersaturated Oxygen Therapy Following PCI in Acute Coronary Syndrome With Cardiogenic Shock: A Randomized Study

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Characterizing the Untapped Pool of HIV+ Donors for Heart Transplantation

SHOCK-PRECISION: Early Phenotype-Guided Mechanical Circulatory Support in Cardiogenic Shock

Beyond the Stethoscope: AI in HF Diagnosis and Phenotyping

A Retrospective Analysis of Heart Failure Hospitalization Trends in Patients with Functional Mitral Regurgitation in a Real-world Clinical Setting

Artificial Intelligence: Framing the Future of HF Diagnostics and Clinical Decision Making

PARACHUTE-PCI: An adaptive, sham-controlled, simultaneous crossover trial of microaxial flow pumps to prevent cardiogenic shock during high risk PCI

Overview of Gene Therapies for Specific Cardiomyopathies

Not Quite PGD: Classification of Abnormal Hemodynamic Phenotypes after Heart Transplant

The Emperor Rises: First In Vitro and In Vivo Evaluation of SynCardia’s Electromechanical Total Artificial Heart

No: Only Select Patients Should Receive a Remote Monitoring Device

Yes: Most Patients Discharged from a HF Hospitalization Should Receive a Remote Monitoring Device

NO: The Evidence is Not Strong Enough to Support TEER in Moderate MR in HF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content